O'Brien Greene & Co’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $704K | Hold |
7,675
| – | – | 0.19% | 74 |
|
|
2026
Q1 | $654K | Hold |
7,675
| – | – | 0.19% | 81 |
|
|
2025
Q4 | $606K | Sell |
7,675
-350
| -4% | -$27.4K | 0.18% | 76 |
|
|
2025
Q3 | $642K | Sell |
8,025
-1,017
| -11% | -$86.8K | 0.2% | 72 |
|
|
2025
Q2 | $822K | Hold |
9,042
| – | – | 0.27% | 61 |
|
|
2025
Q1 | $847K | Hold |
9,042
| – | – | 0.28% | 54 |
|
|
2024
Q4 | $822K | Buy |
9,042
+42
| +0.5% | +$4.01K | 0.27% | 61 |
|
|
2024
Q3 | $934K | Sell |
9,000
-42
| -0.5% | -$4.28K | 0.29% | 59 |
|
|
2024
Q2 | $877K | Buy |
9,042
+42
| +0.5% | +$3.87K | 0.28% | 59 |
|
|
2024
Q1 | $810K | Hold |
9,000
| – | – | 0.27% | 65 |
|
|
2023
Q4 | $717K | Hold |
9,000
| – | – | 0.25% | 67 |
|
|
2023
Q3 | $640K | Sell |
9,000
-250
| -3% | -$18.7K | 0.23% | 66 |
|
|
2023
Q2 | $712K | Hold |
9,250
| – | – | 0.25% | 64 |
|
|
2023
Q1 | $695K | Sell |
9,250
-250
| -3% | -$18.6K | 0.26% | 63 |
|
|
2022
Q4 | $748K | Sell |
9,500
-21,319
| -69% | -$1.6M | 0.28% | 58 |
|
|
2022
Q3 | $2.16M | Buy |
30,819
+20,546
| +200% | +$1.61M | 0.29% | 58 |
|
|
2022
Q2 | $823K | Hold |
10,273
| – | – | 0.31% | 53 |
|
|
2022
Q1 | $779K | Sell |
10,273
-6
| -0.1% | -$475 | 0.26% | 65 |
|
|
2021
Q4 | $877K | Buy |
10,279
+71
| +0.7% | +$5.54K | 0.29% | 64 |
|
|
2021
Q3 | $771K | Buy |
10,208
+8
| +0.1% | +$635 | 0.28% | 67 |
|
|
2021
Q2 | $829K | Buy |
10,200
+1,700
| +20% | +$139K | 0.3% | 63 |
|
|
2021
Q1 | $670K | Hold |
8,500
| – | – | 0.27% | 71 |
|
|
2020
Q4 | $726K | Hold |
8,500
| – | – | 0.3% | 66 |
|
|
2020
Q3 | $656K | Hold |
8,500
| – | – | 0.31% | 64 |
|
|
2020
Q2 | $622K | Hold |
8,500
| – | – | 0.33% | 63 |
|
|
2020
Q1 | $564K | Hold |
8,500
| – | – | 0.38% | 59 |
|
|
2019
Q4 | $586K | Hold |
8,500
| – | – | 0.3% | 73 |
|
|
2019
Q3 | $624K | Hold |
8,500
| – | – | 0.33% | 68 |
|
|
2019
Q2 | $610K | Sell |
8,500
-400
| -4% | -$28.4K | 0.32% | 70 |
|
|
2019
Q1 | $610K | Hold |
8,900
| – | – | 0.31% | 73 |
|
|
2018
Q4 | $530K | Buy |
+8,900
| New | +$557K | 0.32% | 63 |
|
Other funds holding CL
O'Brien Greene & Co's CL Position: Q2 2026 in Review
O'Brien Greene & Co held its Colgate-Palmolive (CL) position steady in Q2 2026 at 7,675 shares worth $704K. The position accounts for 0.19% of the portfolio, ranked #74.
O'Brien Greene & Co first reported a position in CL in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.16M in Q3 2022. 2,029 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- O'Brien Greene & Co held 7,675 shares of Colgate-Palmolive worth $704K as of Q2 2026.
- O'Brien Greene & Co left its Colgate-Palmolive share count unchanged in Q2 2026.
- Colgate-Palmolive made up 0.19% of O'Brien Greene & Co's portfolio in Q2 2026, its #74 holding.
- O'Brien Greene & Co first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 31 quarters since.
- O'Brien Greene & Co's Colgate-Palmolive position peaked at $2.16M in Q3 2022.
- 2,029 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on O'Brien Greene & Co's 13F filing for Q2 2026, filed 6 Aug 2026.